FDX1 and nonpapillary renal cell carcinoma: To evaluate the cuproptosis-independent role of FDX1, we performed a GSEA analysis of TCGA-KIRC and found that the JAK_STAT pathway was significantly enriched in FDX1_low ccRCC patients.